Stelios Chatzimichail

Stelios Chatzimichail is a Research Fellow at the University of Oxford working in the Antimicrobial Resistance Testing programme, specializing in lab-on-a-chip technologies for rapid bacterial identification in liquid biopsies. His work bridges microfluidics, molecular diagnostics, and antimicrobial susceptibility profiling to address critical challenges in infection management.

He earned his PhD from Imperial College London in 2020, where he developed single-cell analysis tools for circulating tumor cells, establishing his expertise in precision diagnostic platforms.

Dr. Chatzimichail's research focuses on accelerating pathogen detection through microanalytical systems and molecular barcoding, with emphasis on Escherichia coli resistance mechanisms. His work integrates microfluidics, fluorescence microscopy, and citizen science to create scalable diagnostic solutions that bypass traditional culture-based methods.

Recent publications reveal a cohesive trajectory toward point-of-care antimicrobial resistance diagnostics, featuring innovations in adaptive microchannel systems, ribosome phenotyping, and image-based prediction algorithms. These approaches target critical gaps in clinical response times for bloodstream infections.

As part of Oxford's Antimicrobial Resistance Testing programme, he contributes to developing next-generation diagnostic platforms aimed at transforming how clinicians identify bacterial pathogens and determine treatment protocols within hours rather than days.